Access to COVID-19 Vaccines in Countries Hosting Clinical Trials

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.34233?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111821

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

What The Study Did: This study found that among low-, middle- and high-income countries hosting COVID-19 vaccine trials, high-income countries received proportionately more doses, enabling them to more fully vaccinate their populations.

Authors: Reshma Ramachandran, M.D., M.P.P., of the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2021.34233)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.